Expand your career opportunities with CLIMB 2022

Dr. Bill Lombardi is a world-renowned expert in Complex Coronary Disease Therapies, performing over 500 interventions a year, including 250 CTOs.

He continues to develop novel chronic total occlusion (CTO) techniques and technologies, including the inception of a “hybrid algorithm” that facilitates successful, reproducible outcomes in CTO and complex lesion PCI. He has been involved with over 20 new technologies to improve PCI, including guide wires, microcatheters, specialty balloons and novel approaches to reduce radiation and orthopedic injuries to operators.

Dr. Lombardi completed his M.D. at Tulane Medical School and went on to the University of Utah, Salt Lake City for his internal medicine residency and fellowships in cardiology, heart failure/cardiac transplant, and interventional cardiology. He is board certified in interventional cardiology and cardiovascular disease by the American Board of Internal Medicine. He continues to innovate at the University of Washington Medical Center as clinical professor and Director of the Complex Coronary Disease Therapies Program.

Dr. Lombardi’s focus remains improving outcomes through numerous collaborations with his colleagues, industry, and teaching the next generation of CTO operators.

On his free time Dr. Lombardi enjoys spending time with his family on their boat  “Lioness”, fishing, and exploring the outdoors.

Dr Anja Oksnes MD is a Consultant Interventional Cardiologist at Haukeland University Hospital, Bergen, Norway. She has a subspecialty interest in CTO, complex PCI, and TAVI. She has been faculty and a live case operator at several international meetings. Her research interests are in CTO and complex PCI, and she is currently co-Chief Investigator for the Invest CTO study.

Prof. Ernst is a German cardiac electrophysiologist with a special expertise in complex arrhythmias such as atrial fibrillation and ventricular arrhythmia both in paediatric and adult patients. Having studied Medicine in Germany, the United States and Switzerland, she worked for 10 years at the St. Georg Hospital in Hamburg, Germany. In 2005 she obtained her “Habiliation” on catheter ablation techniques for atrial fibrillation at the University of Hamburg-Eppendorf.  In 2007, she accepted the position of Research Lead Electrophysiology at the Royal Brompton and Harefield NHS Foundation Trust in London and is a Professor of Practice (Cardiology) at the National Heart and Lung Institute of Imperial College since 2019.

She is one of the pioneers of remote magnetic navigation and has established this technique from its’ initiation to clinical routine using state of the art equipment including advanced 3D mapping techniques.. Especially patients with congenital heart disease, complex anatomy and drug-refractory arrhythmias are benefitting from these advances and form a major emphasis in Prof. Ernst’s clinical work. She is also a strong advocate for radiation protection measures which does not only benefit her patients but also the cath lab staff. She performs all of her procedures with low or ZERO fluoroscopy.

In the last years, Prof. Ernst’s research has focused on novel imaging techniques to visualize the autonomic nervous system to better understand its’ role for the initiation and maintenance of cardiac arrhythmia as well as tele-robotic interventions & artificial intelligence.

Jonathan P. Piccini, MD, MHS, FACC, FAHA, FHRS is a clinical cardiac electrophysiologist and Associate Professor of Medicine with Tenure at Duke University Medical Center and the Duke Clinical Research Institute. He is the Director of the Cardiac Electrophysiology section at the Duke Heart Center. His focus is on the care of patients with atrial fibrillation and complex arrhythmias, with particular emphasis on catheter ablation and lead extraction. His research interests include the development and conduct of clinical trials to evaluate innovative cardiovascular therapeutics for the care of patients with heart rhythm disorders. He has served as the chairman for several national and international clinical trials and registries, including the American Heart Association-Get with the Guidelines Atrial Fibrillation program. He is an associate editor for the Journal of Interventional Cardiac Electrophysiology and serves on the editorial board of several journals, including Heart Rhythm, the European Heart Journal, JACC: Clinical Electrophysiology, Circulation: Arrhythmia & Electrophysiology and the Journal of Cardiac Electrophysiology. Dr. Piccini has more than 475 publications in the field of heart rhythm medicine and has been the recipient of several teaching and mentorship awards.

Dr. Frances Mae West is an Assistant Professor of Medicine in the Division of Pulmonary, Allergy, and Critical Care Medicine at Thomas Jefferson University Hospital in Philadelphia, PA.  She is the Associate Program Director for the Pulmonary and Critical Care Medicine Fellowship and the founding Program Co-Director of the Internal Medicine Point-of-Care Ultrasound Fellowship.  She also serves as the Critical Care advisor to the Emergency Medicine Ultrasound Fellowship.

She obtained her medical degree from Jefferson Medical College, followed by Internal Medicine internship, residency and Pulmonary & Critical Care Medicine fellowship at the New York-Presbyterian Hospital – Weill Cornell Medical Center.  She is triple board certified in Internal Medicine, Pulmonary Medicine and Critical Care Medicine.  She is a Testamur of the National Board of Echocardiography’s Special Competence in Critical Care Echocardiography, and is currently on track for board certification.

Dr. West is a founding member and co-Director of Jefferson’s Pulmonary Embolism Response Team (JeffPERT).  She is a member of the National PERT Consortium and serves on the Communications Committee.  She is a Course Director for the international Resuscitative Transesophageal Echocardiography (TEE) Workshop.  She is a fellow of the American College of Physicians, and holds active memberships in the American Thoracic Society, American College of Chest Physicians, and the American Institute of Ultrasound in Medicine.

Dr. Maidah Yaqoob has a diverse clinical experience. After completing her medical school, she trained in Internal Medicine at SKMC (Cleveland Clinic) in Abu Dhabi, UAE.  She then completed her Residency training in Internal Medicine at St. Elizabeth Medical Center (TUFTs School of Medicine) in Boston, MA.  She did an additional Chief Resident year at the same institution before starting her Fellowship in Pulmonary Critical Care at University of Illinois at Chicago where she also served as a Chief Fellow.

Her fellowship interests were focused on pulmonary vascular disease, resuscitation, critical care ultrasound, resident/fellow wellness and promoting women in medicine. She also established a support group for patients with pulmonary hypertension and was an active member of the COVID response task force during the first surge. She has now joined Cedars Sinai Medical Center, where she is assigned Co-directorship of the Pulmonary Embolism Response Team. She is currently participating in multiple clinic trials. Her career aims are to help grow the Pulmonary Vascular Disease program and be engaged with fellows’ education, wellbeing and curriculum development.

Beyond medicine, Dr. Yaqoob enjoys singing, hiking, glamping, cooking and is an avid board game player.

Professor Marianne Brodmann is a Medical Specialist in Angiology and
Internal Medicine at the Medical University of Graz, where she serves as
Substitute Head of the Division of Angiology.
Prof Brodmann has been a member of multiple groups, such as Nucleus Working Group
Peripheral Circulation of the ESC and Nucleus DVG (Dachverband Österreichische
Gefäßmedizin) and Nucleus ÖGIA. She served as Secretary and Chairperson of the working
Group Peripheral Circulation of ESC and was President of the ÖGIA from 2012-2014 and
President of The European Society of Vascular Medicine (ESVM) from 2017-2018. She has also
been a National Delegate of the International Union of Angiology (IUA) since 2005.
Prof Brodmann’s research interests include anticoagulation and thrombolysis, new
endovascular technologies in the peripheral field, and evaluation of nature of restenosis.
Additionally, Prof Brodmann has participated in multiple international clinical trials.

Dr. Prakash Krishnan is the System Director of Endovascular Services (Cardiology), and Associate Professor of  Medicine, Cardiology, and Radiology at the Icahn School of Medicine at Mount Sinai. He is a world leader in advanced catheter based therapy for the treatment of complex peripheral arterial disease. As Director, he has developed the Endovascular Division of the Cardiac Cath Lab to become the one of most innovative and respected endovascular programs in the country. He has developed a robust practice and has performed over 10,000 interventional procedures at Mount Sinai.

Dr. Krishnan’s career began with residency in Internal Medicine at St. Vincent’s Medical Center, followed by a Cardiology Fellowship at The Ochsner Clinic Foundation, an Interventional Cardiology Fellowship at The Mount Sinai Hospital, and an Endovascular Intervention Fellowship at North Central Heart Institute.

Dr. Krishnan is a world-renowned interventional cardiologist and vascular interventional expert. He is highly regarded for performing high-risk complex interventions with a passion for amputation prevention and catheter based therapy for advanced peripheral arterial and venous disease.

Dr. Krishnan established multiple community outreach screening programs throughout the greater New York region to allow for early identification of patients with PAD. He spearheaded an initiative with the New York School of Podiatric Medicine to educate the physicians and the students and has an academic appointment as a Clinical Associate Professor in Medical Sciences. Dr. Krishnan also began the venous disease program at Mount Sinai Doctors in Jackson Heights and in the Cardiac Cath Lab at Mount Sinai. During his time here, he has been instrumental in implementing and growing Mount Sinai’s community vascular outreach programs through offices in the network to ensure delivery of the highest quality of care to the greater New York region. This has led community leaders to acknowledge his efforts in education in peripheral arterial disease awareness by honoring him with the Reverend Martin Luther King Legacy Award in recognition for his service.

Dr. Krishnan is an internationally established leader in education. He has been both innovative and progressive, and recognized the opportunity to reach thousands of physicians to help advance the understanding of techniques in the interventional treatment of peripheral arterial disease. In 2012, Dr. Krishnan began to broadcast monthly live peripheral interventions via CCC Live Cases, which has over 10,000 views per month. He founded the Endovascular Fellowship in 2013 with a mission to train highly qualified physicians with the necessary skills to treat patients with vascular disease. From 2009-2015, he was the Endovascular Director of the Live Symposium of Complex Coronary and Vascular Cases and in 2013, he established the Mount Sinai Endovascular Fellows Course to train fellows from institutions all over the globe. Due to COVID-19 virus and the restrictions on large meetings, he hosted this Fellows Course virtually in October 2020 and garnered a global audience of over 250 Fellows. In 2015, Dr. Krishnan advanced international education in peripheral arterial disease through collaboration with the Leipzig Interventional Course to create the LINC Mount Sinai Symposium. This allowed for the education of a worldwide audience in the advanced endovascular techniques for peripheral vascular disease. Each year this course trains hundreds of physicians and fellows from the United States and abroad. He is now expanding this meeting and rebranding it as the New York Endovascular Summit, which is set to take place in October 2021. Dr. Krishnan is also regularly invited to perform live case demonstrations for numerous national and international courses via satellite.

He has received numerous awards and accolades for his contributions. He received the Mentorship in Endovascular Interventions Award in 2018, and the Distinguished Teaching Award in 2017. In addition, he has been included on the America’s Top Physicians and New York Magazine’s list of New York’s Best doctors for several years.

Dr. Krishnan is a dedicated researcher, particularly recognized for his work on drug-coated technology and atherectomy for therapy of the peripheral arterial disease. He was first physician in the United States to use the Drug Coated Balloon (DCB) on a patient. He was a leading enroller in many of the pivotal US trails with DCB’s and atherectomy, and was the Co- National Primary Investigator in the ILLUMENATE pivotal DCB Trial and The Cross Seal trial. He has contributed numerous impactful manuscripts on peripheral arterial disease, book chapters and has edited textbooks on vascular interventions.